Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Valneva ( (VALN) ).
On March 9, 2026, Valneva announced that it would report its full-year 2025 consolidated financial results on March 18, 2026, and host a live webcast at 3 p.m. CET/10 a.m. EDT to discuss the figures and provide a business update. The planned disclosure and webcast underscore the company’s focus on communicating its financial performance and pipeline progress to investors, at a time when its commercial vaccines and advanced candidates in Lyme disease and Shigella remain central to its growth story in the competitive vaccine market.
The most recent analyst rating on (VALN) stock is a Hold with a $8.30 price target. To see the full list of analyst forecasts on Valneva stock, see the VALN Stock Forecast page.
Spark’s Take on VALN Stock
According to Spark, TipRanks’ AI Analyst, VALN is a Neutral.
Valneva’s overall stock score reflects significant financial challenges, including negative profitability and cash flow issues. While technical indicators show neutral momentum, and the earnings call highlighted some positive developments, the company’s high leverage and ongoing losses weigh heavily on the score. Promising clinical advancements provide potential for future growth but are not enough to offset current financial concerns.
To see Spark’s full report on VALN stock, click here.
More about Valneva
Valneva SE is a specialty vaccine company that develops, manufactures and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The group has a track record of advancing multiple vaccines from early R&D to approval, currently markets three proprietary travel vaccines, and is developing late-stage candidates such as a Lyme disease vaccine with Pfizer and the world’s most clinically advanced Shigella vaccine candidate.
Average Trading Volume: 19,264
Technical Sentiment Signal: Buy
Current Market Cap: $904.6M
See more data about VALN stock on TipRanks’ Stock Analysis page.